Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new hearing aid strategy cut through the noise?

NCT ID NCT06138665

Symptom relief Sponsor: Sonova AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests a new noise-reduction strategy in hearing aids for people with severe hearing loss who already use hearing aids. Participants will try an experimental hearing aid and two currently available models to compare how well they understand speech in a noisy room with multiple talkers. The study also measures how much listening effort participants feel. The goal is to see if the new strategy helps people hear better in challenging listening situations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A new noise-reduction strategy built into an experimental hearing aid (Phonak Audeo Infinio Sphere), compared with two currently available hearing aids.
What this could lead to
If successful, this could lead to hearing aids that make it easier for people with severe hearing loss to follow conversations in noisy places like restaurants or parties.
What could go wrong
This is a small exploratory study, so results may not apply to everyone. The new strategy might not outperform existing hearing aids, and individual results can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

Nov 2023

Finished

Mar 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * bilateral and symmetrical severe hearing loss * experienced hearing aid user 6 months+ hearing aid use * good understanding of English language * able and willing to wear RIC style hearing aids with custom earpieces Exclusion Criteria: * unilateral hearing loss * mild hearing loss * inability to follow verbal directions * presence of ear infection, middle ear fluid, dizziness, or worsening of hearing loss within last 90 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss

Contacts and locations

Locations

  • Phonak Audiology Research Center

    Aurora, Illinois, 60504, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.